Search Results - Ruijter, Bart R

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Pegylated-l-asparaginase therapy for feline large cell lymphoma: 82 cases (2017–2020)

    Pegylated-l-asparaginase therapy for feline large cell lymphoma: 82 cases (2017–2020) by Bik, Céline A, Ruijter, Bart R, Van den Bossche, Lindsay, Teske, Erik, Niessen, Stijn JM, Forcada, Yaiza

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Sexual dimorphism in peripheral blood cell characteristics linked to recanalization success of endovascular thrombectomy in acute ischemic stroke

    Sexual dimorphism in peripheral blood cell characteristics linked to recanalization success of endovascular thrombectomy in acute ischemic stroke by Overmars, L. Malin, van Solinge, Wouter W., Ruijter, Hester M. den, van der Worp, H. Bart, Van Es, Bram, Hulsbergen-Veelken, Cornelia A. R., Biessels, Geert Jan, Exalto, Lieza G., Haitjema, Saskia

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Population pharmacokinetics and genetics of oral meltdose tacrolimus (Envarsus) in stable adult liver transplant recipients

    Population pharmacokinetics and genetics of oral meltdose tacrolimus (Envarsus) in stable adult liver transplant recipients by Martial, Lisa C., Biewenga, Maaike, Ruijter, Bastian N., Keizer, Ron, Swen, Jesse J., Hoek, Bart, Moes, Dirk Jan A. R.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial)

    Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial) by Hendriks, Pim, Rietbergen, Daphne D. D., van Erkel, Arian R., Coenraad, Minneke J., Arntz, Mark J., Bennink, Roel J., Braat, Andries E., Crobach, Stijn, van Delden, Otto M., Dibbets-Schneider, Petra, van der Hulle, Tom, Klümpen, Heinz-Josef, van der Meer, Rutger W., Nijsen, J. Frank W., van Rijswijk, Catharina S. P., Roosen, Joey, Ruijter, Bastian N., Smit, Frits, Stam, Mette K., Takkenberg, R. Bart, Tushuizen, Maarten E., van Velden, Floris H. P., de Geus-Oei, Lioe-Fee, Burgmans, Mark C.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    Tacrolimus 4‐hour monitoring in liver transplant patients is non‐inferior to trough monitoring: The randomized controlled FK04 trial

    Tacrolimus 4‐hour monitoring in liver transplant patients is non‐inferior to trough monitoring: The randomized controlled FK04 trial by Ruijter, Bastian N., Tushuizen, Maarten E., Moes, Dirk J. A. R., Klerk, Babs M. de, Hoek, Bart van

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial)

    Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial) by Hendriks, Pim, Rietbergen, Daphne D. D., van Erkel, Arian R., Coenraad, Minneke J., Arntz, Mark J., Bennink, Roel J., Braat, Andries E., Crobach, A. Stijn L. P., van Delden, Otto M., van der Hulle, Tom, Klümpen, Heinz-Josef, van der Meer, Rutger W., Nijsen, J. Frank W., van Rijswijk, Carla S. P., Roosen, Joey, Ruijter, Bastian N., Smit, Frits, Stam, Mette K., Takkenberg, R. Bart, Tushuizen, Maarten E., van Velden, Floris H. P., de Geus-Oei, Lioe-Fee, Burgmans, Mark C.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Dose-Finding Study of the Multitargeted Tyrosine Kinase Inhibitor SU6668 in Patients with Advanced Malignancies

    Dose-Finding Study of the Multitargeted Tyrosine Kinase Inhibitor SU6668 in Patients with Advanced Malignancies by KUENEN, Bart C, GIACCONE, Giuseppe, RUIJTER, Rita, KOK, Astrid, SCHALKWIJK, Casper, HOEKMAN, Klaas, PINEDO, Herbert M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: